NCT04047446View on ClinicalTrials.gov

Liposomal Bupivacaine vs Dexamethasone ISB

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

July 11, 2019

Primary Completion Date

March 15, 2021

Study Completion Date

March 19, 2021

Conditions
Shoulder Pain
Interventions
DRUG

Exparel 133 MG Per 10 ML Injection

10mL of 133mg liposomal bupivacaine with 5mL of 0.5% bupivacaine (15mL total)

DRUG

Dexamethasone

15mL of 0.5% bupivacaine with 4mg of preservative-free dexamethasone will be injected

Trial Locations (1)

10021

Hospital for Special Surgery, New York

All Listed Sponsors
lead

Hospital for Special Surgery, New York

OTHER

NCT04047446 - Liposomal Bupivacaine vs Dexamethasone ISB | Biotech Hunter | Biotech Hunter